Air Water, Sumitomo Seika to tie up with U.S. firm.
Air Water Inc. and Sumitomo Seika Chemicals Co. said Monday they have agreed to tie up with INO Therapeutics Inc. of the United States in the field of nitric oxide gas for use in the medical treatment of hypoxic respiratory insufficiency.
INO has marketed nitric oxide for inhalation to treat newborns suffering from hypoxic respiratory failure in the U.S. since April and plans to ask Japan's Health and Welfare Ministry to approve the use of nitric oxide gas in medical supplies by the end of this month, the two companies said.
After gaining approval, Sumitomo Seika Chemicals will start importing nitric oxide gas from INO as early as next October and Air Water will sell it to hospitals nationwide, they said.
Sumitomo Seika also plans to import the raw materials for nitric oxide gas in order to start producing it at its factory in Yachiyo, Chiba Prefecture, the officials said.
The two companies expect their annual sales to reach around 1 billion yen in the first year.
|Printer friendly Cite/link Email Feedback|
|Comment:||Air Water, Sumitomo Seika to tie up with U.S. firm.|
|Publication:||Japan Weekly Monitor|
|Date:||Nov 13, 2000|
|Previous Article:||Health ministry to survey ex-Japanese detainees in Sakhalin.|
|Next Article:||420 teachers in Osaka to undergo reeducation for playing hooky.|